iFAST Diagnostics

📍 Southampton, United Kingdom🗓 Founded 2022👥 7 employees💰 Last funded Jan 2023
Medical Practices🌐 ifastdiagnostics.com
Website LinkedIn
iFAST is developing a game-changing, rapid antimicrobial susceptibility test, that will enable every patient with bacterial infections to receive the right antibiotic, on time, every time. Currently, these tests take 48-72 hours, but iFASTs tests are 10x faster, cheaper and involve less tedious manual labour. This is a $4bn market and we expect to bring our product to market at the end of next year.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in iFAST Diagnostics?
iFAST Diagnostics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did iFAST Diagnostics last raise funding?
The most recent investment in iFAST Diagnostics recorded on gritt.io was in January 2023.
When was iFAST Diagnostics founded?
iFAST Diagnostics was founded in 2022.
What industry is iFAST Diagnostics in?
iFAST Diagnostics operates in Medical Practices. Find similar Medical Practices investors on gritt.io.
Where is iFAST Diagnostics based?
iFAST Diagnostics is headquartered in Southampton, United Kingdom.